Physician profile
Mark E Choquette
NPI 1992777619
$420.26
in general payments reported to CMS, 2019-2025
13 companies · $47.23 in 2025
The $47.23 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $60.00 · 2021: $46.88 · 2022: $17.13 · 2023: $25.24 · 2025: $47.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $98.09 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.16 | 2020-2021 | |
| Pacira Therapeutics, INC. | $65.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.24 | 2023 | Iovera, Zilretta, Exparel |
| Verona Pharma, INC. | $23.98 | 2025 | Ohtuvayre |
| Vertex Pharmaceuticals Incorporated | $23.25 | 2025 | |
| Amgen INC. | $20.23 | 2019 | |
| Pfizer INC. | $17.44 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $17.13 | 2022 | |
| Allergan, INC. | $16.28 | 2020 | |
| Glaxosmithkline, LLC. | $14.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.77 | 2019 | |
| Bioventus LLC | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Choquette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.